NPHLA Daily
NPHLA Daily
Friday, November 20, 2026 · 4-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Aesthetics & Longevity: 1 trial update, 1 new study
NPHLA tracked 2 new official records on this desk today: 1 trial update, 1 new study. First: New trial registered: SPARk (Sexual Function Outcomes Following Peri-clitoral PRP)
Metabolic signal
What changed today in Metabolic: 2 trial updates
NPHLA tracked 2 new official records on this desk today: 2 trial updates. First: New trial registered: Semaglutide in Alcohol Use Disorder
Regulatory signal
What changed today in Regulatory: 1 safety alert
NPHLA tracked 1 new official record on this desk today: 1 safety alert. First: Medical Device Correction Update Luna® G3 BPAP System (Model LG3800-30VT)
Aesthetics & Longevity signal
New trial registered: SPARk (Sexual Function Outcomes Following Peri-clitoral PRP)
Not applicable, Medstar Health Research Institute. Conditions: Sexual Function. Interventions: Platelet-Rich Plasma (PRP) Injections. Investigational: trial-stage therapies are not approved for the use studied.
AI & Technology signal
What changed today in AI & Technology: 1 final rule
NPHLA tracked 1 new official record on this desk today: 1 final rule. First: Final rule published: HIPAA Privacy Rule: Changes To Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
One thing worth watching
Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…
November 26, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in Aesthetics & Longevity: 1 trial update, 1 new study
- What changed today in Metabolic: 2 trial updates
- What changed today in Regulatory: 1 safety alert
- What changed today in AI & Technology: 1 final rule
- New trial registered: SPARk (Sexual Function Outcomes Following Peri-clitoral PRP) (ClinicalTrials.gov (U.S. National Library of Medicine))
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.

